NSI-189 is a new antidepressant and cognitive booster.
NSI-189 is a novel neurogenic antidepressant. Neurogenic drugs promote the development and growth of new neurons, or brain cells. This means that NSI-189 could potentially repair damaged or missing brain cells that lead to a person being unable to experience happiness – or, in other words, who are depressed.
NSI 189 is currently in research for treating other neurological disorders such as Alzheimer’s disease, brain injury, stroke, traumatic stress disorder